Speech Treatment for Minimally Verbal Children With ASD and CAS

Recruiting now · Not applicable

Conditions studied: Developmental Verbal Dyspraxia, Autism Spectrum Disorder

In brief

Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.

Key facts

Study ID

NCT05066178

Run by

MGH Institute of Health Professions

People needed

20

Starts

2024-05-01

Expected to finish

2030-11-30

Last updated by the study team

2026-03-30

Who can join

Age: 5 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets criteria for Autism Spectrum Disorder
• Able to correctly repeat at least 2 syllables
• Meets criteria for Childhood Apraxia of Speech
• Lives in an environment where child is exposed to English at least 50% of the time

You may not qualify if…

• Poorly controlled seizures
• Factors such as blindness or deafness that contribute to minimally verbal status
• Lives in an environment where English is not spoken at least 50% of the time
• Child experiences behavioral challenges that preclude participation in the study

Where it is running

• MGH Institute of Health Professions — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.